Suchergebnisse - "Procter, M"

PubPharm (27)

1

Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial

enthalten in: ESMO open | 2023

von de Azambuja, E. | Agostinetto, E. | Procter, M. | +19

2

Generic boundaries in the Ophiostomatales reconsidered and revised

enthalten in: Studies in mycology | 2022

von de Beer, Z. | Procter, M. | Wingfield, M. | +2

3

Morphological and molecular characterization of Prosthogonimus falconis n. sp. (Trematoda; Prosthogonimidae), found in a peregrine falcon (Falco peregrinus) (Aves : Falconidae) in the United Arab Emirates

enthalten in: Journal of helminthology | 2022

von Schuster, R. | Gajic, B. | Procter, M. | +3

4

A new species of Raffaelea from beetle-infested Leucaena leucocephala

enthalten in: Fungal systematics and evolution | 2020

von Procter, M. | Nel, W. | Marincowitz, S. | +2

5

Creatine transporter deficiency : Novel mutations and functional studies

enthalten in: Molecular genetics and metabolism reports | 2016

von Ardon, O. | Procter, M. | Mao, R. | +10

6

Sequencing analysis of insulin receptor defects and detection of two novel mutations in INSR gene

enthalten in: Molecular genetics and metabolism reports | 2014

von Ardon, O. | Procter, M. | Tvrdik, T. | +2

7

HER2 staining intensity in HER2-positive disease : relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Zabaglo, L. | Stoss, O. | Rüschoff, J. | +9

8

HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab

enthalten in: Annals of oncology | 2013

von Zabaglo, L. | Stoss, O. | Rüschoff, J. | +9

9

S25 Update of the HERA trial and the role of 1 year Trastuzumab as adjuvant therapy for breast cancer

enthalten in: The breast | 2009

von Gianni, L. | Goldhirsch, A. | Gelber, R. | +11

10

Glucokinase activators as potential antidiabetic agents possessing superior glucose lowering efficacies

enthalten in: Drugs of the future | 2009

von Fyfe, M. | Procter, M.